TRA-1-60-positive/CD45(low) cells found in the peripheral blood of prostate cancer patients with metastatic disease – A proof-of-concept study

PURPOSE: Over 90% of all cancer related deaths are due to metastasis. However, current diagnostic tools can't reliably discriminate between invasive and localized cancers. PATIENTS AND METHODS: In this proof-of-concept study, we employed the embryonic stem cell marker TRA-1-60 (TRA+) to identif...

Descripción completa

Detalles Bibliográficos
Autores principales: Schäfer, Claudia, Ju, Yawen, Tak, Youngbin, Vazquez, Cesar, Han, Sangyoon J., Tan, Edwin, Shay, Jerry W., Holmqvist, Mats, Danuser, Gaudenz, Schopperle, William M., Bubley, Glenn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6994489/
https://www.ncbi.nlm.nih.gov/pubmed/32021935
http://dx.doi.org/10.1016/j.heliyon.2020.e03263

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6994489/
https://www.ncbi.nlm.nih.gov/pubmed/32021935
http://dx.doi.org/10.1016/j.heliyon.2020.e03263

Ejemplares similares